Acute Nicotine Gum and Auditory Brain Responses in Adults With Chronic Tinnitus
Key facts
- Who runs it
- San Diego State University
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 1/2
- People taking part
- 20 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 31 May 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Nicotine polacrilex gum 4 mg
- Placebo gum
- Record updated
- 6 November 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Non-smoking adult, defined as fewer than 100 cigarettes in a lifetime and none in the past year, with a Fagerstrom Test for Nicotine Dependence score of 2 or less and a negative urinary cotinine test
- Chronic subjective tinnitus of at least 6 months' duration
Who cannot take part
- Unstable cardiovascular disease
- Any condition precluding the psychoacoustic tasks
- Current or recent tobacco or nicotine use
- Pregnancy or breastfeeding
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United States
- San Diego State UniversitySan Diego, United StatesContact: Xianhui WangNot yet recruiting
About the trial
What the trial wants to find out
This study tests whether a single dose of nicotine gum changes brain responses to sounds and the ability to detect target sounds in non-smoking adults with chronic tinnitus. In a double-blind, placebo-controlled, within-subject crossover design, each participant attends two sessions and receives a single 4 mg dose of nicotine polacrilex gum at one session and a flavor-matched placebo gum at the other, in random order. After gum administration, EEG is recorded at rest and during an active auditory oddball task. The primary measures are the P3 brain response (amplitude and latency) and oddball task accuracy and reaction time.
The 2 groups in the trial
- Nicotine gum (4 mg)Treatment being tested
Single 4 mg dose of nicotine polacrilex gum, chewed for 20 minutes at 1 Hz using the standardized administration protocol.
Treatment: Nicotine polacrilex gum 4 mg
- Placebo gumPlacebo, for comparison
Flavor-, color-, shape-, and texture-matched placebo gum, chewed under the identical protocol.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Double-Blind, Placebo-Controlled, Within-Subject Crossover Trial of a Single 4 mg Dose of Nicotine Polacrilex Gum on Auditory Oddball P3, Oddball Task Performance, and Resting-State EEG in Non-Smoking Adults With Chronic Tinnitus
- Criteria questions
- Built from NCT07877701, who can take part
- Record updated
- 6 November 2026